Hölttä, Mikko
AstraZeneca (Sweden)
3 papers on CoChatORCID 0000-0001-6024-3686
Most cited papers
- Verified
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 2,049
- Verified
Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
Maugeri, M., Nawaz, M., Papadimitriou, A., Angerfors, A., Camponeschi, A., Na, M., Hölttä, M., Skantze, P., Johansson, S., Sundqvist, M., et al. (2019) · Nature Communications
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 428
- Verified
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
Hölttä, M., Minthon, L., Hansson, O., Holmén-Larsson, J., Pike, I., Ward, M., Kuhn, K., Rüetschi, U., Zetterberg, H., Blennow, K., et al. (2015) · Journal of Proteome Research
Advanced Proteomics Techniques and ApplicationsAlzheimer's disease research and treatments
Cited by 100
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free